SCHEMBL2368294

SCHEMBL2368294

Cc1sc2nc(NCCO)nc(NCc3ccccn3)c2c1-c1ccc2c(c1)OCO2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 5/20 0.47
DYRK1A Q13627 3/20 0.47
FYN P06241 1/20 0.45
RET P07949 1/20 0.42
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 3/20 0.40
MAPK1 P28482 3/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP2C19 P33261 2/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HIF1A Q16665 1/20 0.40
TUBB4A P04350 2/20 0.39
TUBB P07437 2/20 0.39
TUBA3C P0DPH7 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2369270 0.89 PDCD1 (0.39) CLK4DYRK1ARETMEN1KMT2A
SCHEMBL2368855 0.88 CLK4 (0.48) CLK4DYRK1AFYNRETMEN1
SCHEMBL2369514 0.86 CLK4 (0.46) CLK4DYRK1AFYNRETMEN1
SCHEMBL2368771 0.85 CLK4 (0.47) CLK4DYRK1AFYNRETMEN1
SCHEMBL2368953 0.85 KCNH2 (0.48) MEN1KMT2AMAPK1SMN1; SMN2KCNH2
SCHEMBL2368909 0.84 KCNA5 (0.44) MEN1KMT2AMAPK1SMN1; SMN2KCNH2
SCHEMBL2368531 0.84 CLK4 (0.49) CLK4DYRK1AFYNRETMEN1
SCHEMBL3382804 0.83 DYRK1A (0.46) CLK4DYRK1AFYNRETMEN1
SCHEMBL6357999 0.81 CLK4 (0.49) CLK4DYRK1AFYNRETMEN1
SCHEMBL2369071 0.81 DYRK1A (0.44) CLK4DYRK1AFYNRETMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022076-B2 Thieno[2,3-d]pyrimidine derivatives as potassium channel modulators; antiarrhythmia agents XENTION LIMITED (GB) 2011-09-20 US disclosed
EP-1641803-B3 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS XENTION LTD (GB) 2010-12-08 EP disclosed
EP-1641803-B1 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS XENTION LTD (GB) 2009-03-18 EP disclosed
EP-1641803-A1 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS Xention Discovery Limited (GB) 2006-04-05 EP disclosed
WO-2004111057-A1 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS XENTION DISCOVERY LIMITED (GB) 2004-12-23 WO disclosed